Brief: CytoTools: issue of a convertible bond and cash capital increase

bioXXmed AG

30/03/2017 10:11

March 30 (Reuters) - CytoTools AG  T5OG.DE : 
    * Issue of a convertible bond with a total nominal value of 
up to 0.6 million euros and a cash capital increase of nominally 
up to 0.2 million euros 
    * The plan is the issue in tranches of at least 100,000.00 
euros ($107,390.00) 
    * Convertible bond is intended to allow conversion into up 
to 600,000 shares of the company at an interest rate of 5.0%, a 
conversion price of 17.50 euros and a maturity until March 31, 
2022 
    * Issue proceeds from capital measure would amount to 
roughly 2.8 million euros at the current price level 
    * Convertible bond issue: possible issue proceeds would 
amount to around 10.5 million euros in total placement 
 
Source text for Eikon:  ID:nEQ2bTVy4  
Further company coverage:  T5OG.DE  
 
($1 = 0.9312 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 722 0920;))